U.S. markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.34%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.43%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.16%)
     
  • BTC-USD

    47,900.39
    -457.00 (-0.95%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

New Strong Sell Stocks for July 14th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

Cohu, Inc. COHU engages in the semiconductor test and inspection equipment, and printed circuit board test equipment businesses. The Zacks Consensus Estimate for its current year earnings has been revised 2.5% downward over the last 30 days.

Nutriband Inc. NTRB develops a portfolio of transdermal pharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.

Helen of Troy Limited HELE designs, develops, imports, markets, and distributes a portfolio of consumer products. The Zacks Consensus Estimate for its current year earnings has been revised 11% downward over the last 30 days.

Cornerstone Building Brands, Inc. CNR designs, engineers, manufactures, markets, and installs external building products. The Zacks Consensus Estimate for its current year earnings has been revised 7.9% downward over the last 30 days.

Selecta Biosciences, Inc. SELB is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 7.3% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cohu, Inc. (COHU) : Free Stock Analysis Report
 
Helen of Troy Limited (HELE) : Free Stock Analysis Report
 
Selecta Biosciences, Inc. (SELB) : Free Stock Analysis Report
 
Cornerstone Building Brands, Inc. (CNR) : Free Stock Analysis Report
 
Nutriband Inc. (NTRB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research